Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Operating Leases: 2019-2025

Historic Operating Leases for Rockwell Medical (RMTI) over the last 7 years, with Sep 2025 value amounting to $3.0 million.

  • Rockwell Medical's Operating Leases fell 16.70% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 16.70%. This contributed to the annual value of $1.7 million for FY2024, which is 18.56% up from last year.
  • As of Q3 2025, Rockwell Medical's Operating Leases stood at $3.0 million, which was down 12.16% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Operating Leases ranged from a high of $7.4 million in Q1 2022 and a low of $1.4 million during Q4 2023.
  • Over the past 3 years, Rockwell Medical's median Operating Leases value was $3.5 million (recorded in 2025), while the average stood at $3.1 million.
  • As far as peak fluctuations go, Rockwell Medical's Operating Leases surged by 223.28% in 2021, and later tumbled by 56.16% in 2022.
  • Quarterly analysis of 5 years shows Rockwell Medical's Operating Leases stood at $5.9 million in 2021, then tumbled by 56.16% to $2.6 million in 2022, then tumbled by 44.48% to $1.4 million in 2023, then climbed by 18.56% to $1.7 million in 2024, then decreased by 16.70% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $3.5 million for Q2 2025, and $2.9 million during Q1 2025.